Interpace Diagnostics Group, In (NASDAQ:IDXG) last traded at $1.52 having a low of $1.51 and high of $1.62. The swing makes the stock one of the day’s most volatile.
It is currently trading at $1.52 a great deal higher than $1.27, the 50 day moving average and quite a bit below the 200 day moving average of $1.71. The 50 day moving average was up by +19.96% and the 200 day average went down by -11.09%.
Traders are more bearish on Interpace Diagnostics Group, In of late if you put credence in the change in short interest. The firm had a rise in short interest from August 15, 2017 to August 31, 2017 of 44.53%. Short shares increased from 2,732,938 to 3,949,802 over that timeframe. Days to cover decreased from 1.0 to 1.0 and the percentage of shorted shares is 0.41% as of August 31.
Recent Analyst Ratings
Equity analyst Maxim Group began coverage of the stock with an initial rating of “Buy”.
Interpace Diagnostics Group, Inc., formerly PDI, Inc., launched on February 10, 1998, is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management. The Company operates through molecular diagnostics segment, which focuses on developing and commercializing molecular diagnostic tests, leveraging the technology and personalized medicine for patient diagnosis and management..